Cargando…

Extended gene panel testing in lobular breast cancer

Purpose: Lobular breast cancer (LBC) accounts for ~ 15% of breast cancer. Here, we studied the frequency of pathogenic germline variants (PGVs) in an extended panel of genes in women affected with LBC. Methods: 302 women with LBC and 1567 without breast cancer were tested for BRCA1/2 PGVs. A subset...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Veen, Elke M., Evans, D. Gareth, Harkness, Elaine F., Byers, Helen J., Ellingford, Jamie M., Woodward, Emma R., Bowers, Naomi L., Wallace, Andrew J., Howell, Sacha J., Howell, Anthony, Lalloo, Fiona, Newman, William G., Smith, Miriam J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964550/ https://www.ncbi.nlm.nih.gov/pubmed/33763779 http://dx.doi.org/10.1007/s10689-021-00241-5

Ejemplares similares

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
por: Evans, D. Gareth, et al.
Publicado: (2021)

Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
por: Woodward, Emma R., et al.
Publicado: (2021)

High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer
por: Evans, D Gareth, et al.
Publicado: (2022)

Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
por: Hyder, Zerin, et al.
Publicado: (2020)

The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
por: Evans, D. Gareth, et al.
Publicado: (2021)

Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women
por: Evans, D. Gareth, et al.
Publicado: (2021)

A Dominantly Inherited 5′ UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer
por: Evans, D.Gareth R., et al.
Publicado: (2018)

Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer
por: Evans, D.Gareth, et al.
Publicado: (2021)

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
por: Evans, D. Gareth R., et al.
Publicado: (2019)

Germline FFPE inherited cancer panel testing in deceased family members: implications for clinical management of unaffected relatives
por: Bennett, Sarah, et al.
Publicado: (2021)

Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers
por: Evans, DG, et al.
Publicado: (2017)

A case–control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density
por: Brentnall, Adam R., et al.
Publicado: (2019)

Gene panel testing for breast cancer should not be used to confirm syndromic gene associations
por: Evans, D. Gareth, et al.
Publicado: (2018)

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
por: Evans, D Gareth, et al.
Publicado: (2008)

Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores
por: Evans, D. G., et al.
Publicado: (2016)

Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
por: Evans, D. Gareth, et al.
Publicado: (2019)

Metaplastic breast cancer and BRCA1: first strong evidence of a link
por: Evans, D. Gareth R, et al.
Publicado: (2023)

Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program
por: Wright, Stuart J., et al.
Publicado: (2023)

Magnitude and attributed reasons for adult weight gain amongst women at increased risk of breast cancer
por: Pegington, Mary, et al.
Publicado: (2022)

Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987–2020)
por: Howell, Anthony, et al.
Publicado: (2020)

Implementing Risk-Stratified Breast Screening in England: An Agenda Setting Meeting
por: McWilliams, Lorna, et al.
Publicado: (2022)

Assessment of mismatch repair deficiency in ovarian cancer
por: Crosbie, Emma J, et al.
Publicado: (2021)

Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?
por: Leventea, Eleni, et al.
Publicado: (2021)

A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast.
por: Harris, M., et al.
Publicado: (1984)

Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers
por: Evans, D Gareth, et al.
Publicado: (2022)

Increased risk of breast cancer in neurofibromatosis type 1: current insights
por: Howell, Sacha J, et al.
Publicado: (2017)

Polygenic risk scores and breast cancer risk prediction
por: Roberts, Eleanor, et al.
Publicado: (2023)

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels
por: Crosbie, Emma J., et al.
Publicado: (2020)

Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?
por: Prosperi, Mattia CF, et al.
Publicado: (2014)

Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
por: Gareth Evans, D., et al.
Publicado: (2023)

Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
por: Gareth Evans, D., et al.
Publicado: (2023)

Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials
por: Cuzick, Jack, et al.
Publicado: (2017)

30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes
por: Woodward, Emma R., et al.
Publicado: (2021)

Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study
por: Evans, D. Gareth R., et al.
Publicado: (2019)

Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study
por: Evans, D. Gareth R., et al.
Publicado: (2019)

Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology
por: McCart Reed, Amy E, et al.
Publicado: (2018)

The Genomic Landscape of Lobular Breast Cancer
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Extending research impact by sharing maker information
por: Howell, Larry L., et al.
Publicado: (2023)

Evaluating the Acceptance and Usability of an App Promoting Weight Gain Prevention and Healthy Behaviors Among Young Women With a Family History of Breast Cancer: Protocol for an Observational Study
por: Pegington, Mary, et al.
Publicado: (2022)

Correction: Evaluating the Acceptance and Usability of an App Promoting Weight Gain Prevention and Healthy Behaviors Among Young Women With a Family History of Breast Cancer: Protocol for an Observational Study
por: Pegington, Mary, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s0rbu46dtr6239tdcep26jea11